Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 49, 2003 - Issue 1
78
Views
3
CrossRef citations to date
0
Altmetric
Research Article

VARIATION OF CHROMOGRANIN A SERUMLEVELS AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE ADENOCARCINOMA

, , , , &
Pages 39-48 | Published online: 09 Jul 2009

  • Abrahamsson PA (1999): Neuroendocrine differentiation in prostatic carcinoma. Prostate 39:135-148.
  • Ahlgren G, Pedersen K, Lundberg S, Aus G, Hugosson J, Abrahemsson PA (2000): Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate 42:274-279.
  • Berruti A, Dogliotii L, Mosca A (2000): Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer 88:2590-2596.
  • Bjork T, Ljungberg B, Piironen T, Abrahamsson P, Pettersson K, Cockett ATK (1998): Rapid exponential elimination of free prostate specific antigen contrasts the slow capacity-limited elimination of PSA complexed to alpha-1-antichymotrypsin from serum. Urology 51:57-62.
  • Bonkhoff H (1998): Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation and androgen receptor status. Prostate (suppl) 8:18-22.
  • Brandle E, Hautmann O, Bachem M (1999): Serum half-life time determination of free and total prostate specific antigen following radical prostatectomy: a critical assessment. Urology 53:722-730.
  • Casella R, Budendorf L, Sauter G, Moch H, Mihatsch MJ, Gasser TC (1998): Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. J Urol 160:406-410.
  • Cohen RJ (1991): Neuroendocrine cells: a new prognostic parameter in prostate cancer. Br J Urol 68:258-262.
  • Di Sant' Agnese PA (1992): Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268.
  • Helpap B, Kollermann J, Oehler U (1999): Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance and future therapeutic perspectives. Urol Int 62:133-138.
  • Kanno T, Asada N, Yanase H, Iwanaga T, Ozaki T (1999): Salivary secretion of highly concentrated chromogranin A in response to noradrenaline and acetylcholine in isolated and perfused rat submandibular glands. Exp Physiol 84:1073-1083.
  • Krijnen J, Jansen P, Ruizeveld de Winter JA, van Kimpen H, Schroeder F, van der Kwast T (1993): Do neuroendocrine cells in human prostate cancer express androgen receptors? Histochemistry 100:393-398.
  • Krupski T, Petroni GR, Frierson HF (2000): Microvessel density, p53, retinoblastoma and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate. Urology 55:743-749.
  • Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT (2001): Proteolytic cleavage of chromogranin A by plasmin: selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem 276:25022-25029.
  • Lilja H, Haese A, Bjork T, Friedrich MG, Piironen T (1999): Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy. J Urol 162:2029-2035.
  • Moftaquir-Handaj A, Barbe F, Barbarino-Monnier P (1995): Circulating chromogranin A and catecholamines in human fetuses at uneventful birth. Pediatr Res 37:101-105.
  • Monti S, Sciarra A, Falasca P, Di Silverio F (2000): Serum concentrations and prostatic gene expression of chromogranin A and PSA in patients affected by prostate cancer and benign prostatic hyperplasia. J Endocrin Invest 23 (suppl 8):53.
  • O'Connor DT, Bernstein KN (1984): Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311:764-770.
  • Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzel DJ, Walsh PC (1998): Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766-772.
  • Partin AW, Piantadosi S, Subong ENP, Kelly CA, Hortopan S, Chan DW (1996) Clearance rate of serum free and total PSA following radical retropubic prostatectomy. Prostate (suppl) 7:35-39.
  • Sanchez-Margalet V, Goberna R (1993): Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat. Peptides 14:797-799.
  • Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS (1987): Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909-916.
  • UICC (1997): TNM Klassification Maligner Tumoren, ed 5. Berlin: Springer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.